Page 34 - หนังสือประชุมวิชาการยาเสพติดแห่งชาติ 2568 ครั้งที่ 25
P. 34
8. Reduced drug use is a meaningful treatment outcome for people with stimulant use
disorders. National Institute of Health. U.S. Department of Health & Human Services.
January 10, 2024
9. American Society of Addiction Medicine. Engagement and Retention of Nonabstinent
Patients in Substance Use Treatment: Clinical Consideration for Addiction Treatment
Providers. October 2024. Accessed March 6, 2025. https://www.asam.org/quality-
care/clinical-recommendations/asam-clinical-considerations-for-engagement-and-
retention-of-non-abstinent-patients-in-treatment.
10. Maureen PB, Eman G, Lien J, et al. Commentary: Clinical Considerations for Engagement
and Retention of Nonabstinent Patients in Care. Journal of Addiction Medicine 2025;
Volume 00, Number 00.
11. Nora D. Volkow. Guest Editorial – Advancing Reduction of Drug Use as an Endpoint in
Addiction Treatment Trials. The American Society of Addiction Medicine (ASAM) Weekly
on March 18, 2025.
22
